Crystal structure of [1,2,4] triazolo[4,3- b ]pyridazine derivatives as BRD4 bromodomain inhibitors and structure–activity relationship study
Abstract BRD4 contains two tandem bromodomains (BD1 and BD2) that recognize acetylated lysine for epigenetic reading, and these bromodomains are promising therapeutic targets for treating various diseases, including cancers. BRD4 is a well-studied target, and many chemical scaffolds for inhibitors h...
Main Authors: | Jung-Hoon Kim, Navin Pandit, Miyoun Yoo, Tae Hyun Park, Ji U Choi, Chi Hoon Park, Kwan-Young Jung, Byung Il Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-37527-w |
Similar Items
-
[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.
by: Fedorov, O, et al.
Published: (2014) -
Synthesis and Structure–Activity Relationships of Aristoyagonine Derivatives as Brd4 Bromodomain Inhibitors with X-ray Co-Crystal Research
by: Minjin Yoo, et al.
Published: (2021-03-01) -
The Structural and Optical Properties of 1,2,4-Triazolo[4,3-<i>a</i>]pyridine-3-amine
by: Lucyna Dymińska, et al.
Published: (2022-01-01) -
Synthesis and antiproliferative activity of 2-(([1,2,4]triazolo[4,3-b]- pyridazin-6-yloxy)methyl)-2,4-dimethyl-3,4-dihydro-2H-benzo[b][1,4]oxazine derivatives
by: Miloš Ilić, et al.
Published: (2011-10-01) -
Bromodomain-Containing Protein BRD4 Is Hyperphosphorylated in Mitosis
by: Ranran Wang, et al.
Published: (2020-06-01)